News About: Pharm. Industry
Listed pharmaceutical companies recorded worst business operation in 1998.
After the IMF economic crisis the business management of 23 leading listed pharmaceutical companies appeared with the lowest sales and extremely deteriorated profits during 1998 fiscal year ending at Dec. 31. (refer t...
Multinational corp. infiltrated to segmented makets with special drugs.
The foreign invested drug companies strove hard for expansion of local pharmaceutical market shares with excellent and special therapeutic product lines such as antidepressants, antiemetics, anti-impotence and anti-he...
Drug Industry may litigate to massive drug price slash.
The drug industry along with the KPMA intends to litigate against the government if the MOHW attempts to slash massive drug prices with other unilateral application of rates than conventional 24.17% of distribution ma...
1998 sales growth of drug manufacturers and wholeslaers.
1998 sales growth of drug manufacturers and wholeslaers 3% and 8% repsectively.
According to "1998 tax report" prepared and declared to the Tax Office by the Pharmaceutical Honor Tax Report Union, the tot...
KRPMA now on standing director's system.
Mr. Paul Lee, the president of KRPMA, a foreign invested company organization officially inaugurated his new job from Jan. this year. At present about 22 foreign invested companies joined the Association, which found ...
KPMA to be operated under leadership of Representative Director.
At the 2nd directorate meeting of the KPMA on March 3 it was determined that the job and responsibility of the Chairman and the Representative Director are separated and clearly defined in which all Association operat...
2nd generation executives dominated KPMA.
At the 54th general meeting of KPMA on Feb. 25 Mr. Lim Sung-ki (Chairman of Hanmi Pharm. Co.) and additional 5 deputy chairmen were newly elected, which showed new faces of top executives but pointed it out not so...
Drug industry reinforced OTC business just ahead massive slash of insurance drug prices.
The drug industry has recently shown a rapid changing movement for their business policies more to the OTC oriented amid a full scale implementation of the open price labelling system from March 1 and an impending thr...
Drug production activity extremely low due to IMF economic woes.
According to the KPMA statistics, the pharmaceutical production recorded an unprecedented negative growth figure in 1998 by 3% decreased from 8.6% growth of the previous year, almost 10% points drop, reflecting seriou...
Mr. Lim Sung-ki appointed to new chairman of KPMA.
-Top management seats increased to 10 deputy chairmen and 50 directors.
The KPMA took the 54th general meeting at 2 pm on Feb. 25 and elected the new 17th chairman as Mr. Lim Sung-ki, the chairman of Hanmi Phar...
